<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04007575</url>
  </required_header>
  <id_info>
    <org_study_id>APHP190470</org_study_id>
    <nct_id>NCT04007575</nct_id>
  </id_info>
  <brief_title>Study of New Imaging Criteria for the Diagnosis of Caroli's Disease</brief_title>
  <acronym>IMACA</acronym>
  <official_title>Magnetic Resonance CholangioPancreatography Signs for the Diagnosis of Caroli Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Caroli disease is a very rare pathology that can be revealed early in childhood or in&#xD;
      adulthood, whose diagnosis is based on Magnetic Resonance CholangioPancreatography, which&#xD;
      shows the communication of these malformations with the rest of the biliary tree and allows&#xD;
      to eliminate biliary stenosis. The radiologist has a central role in the diagnostic&#xD;
      orientation between malformative intra-hepatic bile duct dilatation and obstructive benign or&#xD;
      malignant intra-hepatic bile duct dilatation dilatation. However, imaging of Caroli disease&#xD;
      is polymorphous and therefore subject to misinterpretation. The benefit of this research is&#xD;
      to reduce diagnostic errors by highlighting imaging criteria specific to the Caroli disease&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Magnetic Resonance CholangioPancreatography will have been performed in all patients&#xD;
      using different Magnetic Resonance Imaging systems (Gyroscan Intera, Philips Medical Systems,&#xD;
      Best in the Netherlands, Magnetom Avanto, Siemens Medical Solutions, and Signa Hdxt, General&#xD;
      Electric Medical Systems) with a free-breathing three-dimensional high-spatial-resolution&#xD;
      Fast Spin Echo sequence and/or a breath-hold two-dimensional single-shot sequence. Magnetic&#xD;
      Resonance CholangioPancreatography may also include a Fast Spin Echo weighted T2-weighted&#xD;
      sequence with fat-spectral saturation, a T1-weighted breath-suppressed gradient echo pulse&#xD;
      sequence and a chemical shift sequence in phase and opposite phase, in the axial plane, and a&#xD;
      weighted three-dimensional T1 saturated fat sequence after intravenous administration of&#xD;
      gadolinium chelate. Images will be analyzed in consensus by two abdominal radiologists on a&#xD;
      Picture Archiving and Communication System station and compared with the pathological&#xD;
      results.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 18, 2020</start_date>
  <completion_date type="Actual">December 1, 2020</completion_date>
  <primary_completion_date type="Actual">September 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Intra-hepatic bile duct dilatation</measure>
    <time_frame>2 years</time_frame>
    <description>study of intra-hepatic bile duct shape (qualitative measurement)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Intra-hepatic bile duct dilatation</measure>
    <time_frame>2 years</time_frame>
    <description>intra-hepatic bile duct localisation (qualitative measurement)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Intra-hepatic bile duct dilatation</measure>
    <time_frame>2 years</time_frame>
    <description>biliary calculi (qualitative measurement)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Intra-hepatic bile duct dilatation</measure>
    <time_frame>2 years</time_frame>
    <description>dot sign (qualitative measurement)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Intra-hepatic bile duct dilatation</measure>
    <time_frame>2 years</time_frame>
    <description>liver abnormalities (qualitative measurement)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Intra-hepatic bile duct dilatation</measure>
    <time_frame>2 years</time_frame>
    <description>signs of portal hypertension (qualitative measurement)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pathological examination</measure>
    <time_frame>2 years</time_frame>
    <description>Absence or presence of tumors</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pathological examination</measure>
    <time_frame>2 years</time_frame>
    <description>Absence or presence of calculi</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Biology</measure>
    <time_frame>2 years</time_frame>
    <description>bilirubin level</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Biology</measure>
    <time_frame>2 years</time_frame>
    <description>Alkaline phosphatase level</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Biology</measure>
    <time_frame>2 years</time_frame>
    <description>Creatinine level</description>
  </secondary_outcome>
  <enrollment type="Actual">61</enrollment>
  <condition>Caroli Disease</condition>
  <condition>Magnetic Resonance Imaging</condition>
  <condition>Cholangiopancreatography</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Magnetic Resonance CholangioPancreatography</intervention_name>
    <description>The imaging data will be collected from the hospital records and image archiving system of the radiology departments of the University Hospitals</description>
    <other_name>Magnetic Resonance Imaging</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with illness or Caroli syndrome&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  were patients identified in the database of the hospitals who underwent&#xD;
&#xD;
          -  a diagnosis of Caroli disease on an imaging report with bile duct dilatation limited&#xD;
             to the intrahepatic biliary tree and&#xD;
&#xD;
          -  an available Magnetic Resonance CholangioPancreatography on a Picture Archiving and&#xD;
             Communication System.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  obstructive benign or malignant proximal biliary stricture on Magnetic Resonance&#xD;
             CholangioPancreatography&#xD;
&#xD;
          -  prior surgical interventions for hepatobiliary disease except cholecystectomy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>LEWIN MAITE, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Paul Brousse hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Maite Lewin</name>
      <address>
        <city>Le Kremlin-Bicêtre</city>
        <zip>94804</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>June 4, 2019</study_first_submitted>
  <study_first_submitted_qc>July 2, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 5, 2019</study_first_posted>
  <last_update_submitted>November 15, 2021</last_update_submitted>
  <last_update_submitted_qc>November 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Caroli Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

